Abstract
I "Introduction"
Various agents have been used for intravenous induction of anesthesia. Etomidate is one of the popular new intravenous anesthetic agent, which can be administered during induction of general anaesthesia or sedation for short procedure. Etomidate is a hypnotic drug without analgesic property [1] [2] [3] . The intravenous administration of up to 0.6mg/kg of Etomidate to patients with severe cardiovascular disease has little or no effect on myocardial metabolism, cardiac output, peripheral circulation or pulmonary circulation [5] [6] [7] . Etomidate is rapidly metabolised in the liver. Etomidate injection has pain on injection as an unpleasant adverse effects of this drug. Propylene glycol formulated in etomidate may damage vascular endothelium and produce pain [17] [18] [19] . Several techniques and drugs have been proposed over the years to reduce the incidence and severity of such pain [4, 16] . The aim of the present prospective non randomised controlled single-centre double blind study was to compare the incidence of pain on injection with Etomidate with pre treatment of ondansetron and lignocaine.
II Methodology
Forty patients posted for elective surgery requiring general anesthesia were included in the study. Patients of either gender between age of 18 and 65 years belonging to American Society of Anesthesiologist (ASA) Physical Status 1, 2, and 3 were included in the study. Exclusion criteria were Patient refusal, ASA status 4&5, emergency surgeries, patients suffering from neuromuscular disorders, peripheral vascular disease, hypothyroidism, history of cardiopulmonary disease, psychological disease and diabetes mellitus. If patients have history of allergic response to either, Etomidate or 5HT3 receptor antagonist, and patients who received any analgesic or sedative drugs during the previous 24hours prior to surgery were excluded from the study.
Selected patients were not given any premedication. On arriving to Operating room (OR) 20G IV cannula inserted on dorsum of both hands and both flushed with100ml of normal saline. Venous drainage was occluded with elastic band in the both hands at midarm. The syringes were loaded and labelled A & B, both will have equal volumes of drug 2ml & in same quantity of syringes (2ml), Syringes are handed over to anaesthetist who is administering the drug. The observer as well as the patient is blinded for the content of the syringes. Observer will evaluate pain score by Verbal rating score (VRS). The Anesthetist will administer drug in the right hand side cannula over 30 seconds and elastic band is removed. After one minute drug B is administered in the other hand followed by one ml of Etomidate Injection. VRS is assessed by the Observer. The person who loaded the drug knows about drug Label A & B will interpret with data (result). Then patents were induced with etomidate with 0.3 mg/kg dosage, 1ml of etomidate=2mg. Before injection Drugs, Hemodynamic parameters (Heart rate, Non invasive Blood Pressure, SPO2) are noted, and after completion of procedure, Hemodynamic parameters are recorded. Recovery from anaesthesia was recorded as the time taken from the end of operation to the patient opening his eyes on command. The patient remained in the recovery ward for at least two hour postoperatively. Assessments: Pain was measured using verbal rating scale, Pain score (0: no pain, 1:mild pain, 2:moderate pain, 3:severe pain, 4:extreme pain). The assessments were based on the patient's response during the injection of the study drug.
III Ethical
Study was started after getting ethical clearance committee and procedures followed were in accordance with the Ethical Standards of Yenepoya University Ethics Committee.
Statistical analysis
Wilcoxon sign rank test is used to compare both drugs. Analysis is performed using SPSS Version 22.
IV Results
The age weight and ASA physical status are presented in table1. A total number of 40 patients (male=57.50%, female=42.50%). The mean age of patients was 42.85, The preoperative BP, HR, SPO2 scores are reported as (Mean± SD). The mean of pain score of etomidate after pre-administration of intravenous lignocaine BP (124.6±14.1), HR (67.05±5.56), SPO2 (0.97±0.017). The mean of pain score of etomidate after post-administration of intravenous lignocaine BP (125.25±14.32), HR(72.5±6.51), SPO2(0.97±0.014). There was transient rise in heart rate in patients suffering from pain of verbal rating scale(VRS) score 2-3 in both the labelled drugs, but no changes in blood pressure were noted. After etomidate injection no significant excitatory signs like hypertension, spontaneous movements twitching, tremor and respiratory effects like cough hiccup and laryngospasm were noted. There is significant difference between ondansetron and lignocaine on prevention of injection pain caused by etomidate during induction of anesthesia (P value<0.01) P<.001, therefore it is statistically significant, That is this study illustrates that ondansetron is better then lignocaine on prevention of injection pain caused by etomidate during induction of anesthesia.
Table1:

V Discussion
Etomidate is a well-known substituted imidazole induction agent that shares most of the beneficial characteristics of propofol as (rapid onset/offset and minimal residual sedation) and is also associated with a very high degree of hemodynamic stability [7] [8] [9] . Although etomidate cause adrenocortical suppression, a single injection which is used to induce anaesthesia will only produce a transient and clinically insignificant interference with adrenocortical function. Because of its Hemodynamic stability it is preferred agent to induce anaesthesia in patients with ischemic heart disease, valvular heart disease, patients with cardiomyopathy and with any patients with poor ventricular function [5] [6] [7] [8] . However, its use is limited by two major side effects, pain on injection and involuntary movements [14] [15] . Patients are unaware of the involuntary movements, which do not appear to cause any sequel; but pain on injection is distressing to the patient, so it is a major disadvantage. Although the underlying mechanism is still not fully understood, the explanation for the pain included endothelial irritation, osmolality differences, unphysiological pH and the activation of mediators. The initial component of pain, involving immediate stimulation of nociceptors and free nerve endings seems to be associated mainly with the concentration of free drugs within the aqueous phase of the emulsion. The delayed component of pain appearing within half a minute, is also believed to result from interaction with nociceptors and free nerve endings; however, promoted by local vasodilatation and hyper permeability induced by bradykinins possibly also prostaglandin E2 [11] [12] [13] . Pain on injection is reduced by using large veins, various agents to etomidate solutions and changing the etomidate formulations, Pre treatment with a small dose of lignocaine, opiates, non steroidal anti-inflammatory drugs, ketamine, esmolol/metoprolol, magnesium, clonidine/ephedrine combination, dexamethasone, and metoclopramide, all have been tested with variable efficacy [11, 15] . Ondansetron which is a commonly used drug to prevent Post operative nausea and vomiting is shown to be effective in preventing the pain of propofol Injection. If Ondansetron is effective in reducing the pain of etomidate injection, the we can avoid other drug which is exclusively used to prevent pain of etomidate injection and thereby we can avoid any adverse effect of that drug. This study shows pre treatment with lignocaine 1% gives better pain relief when compared to ondansetron.
VI Conclusion
This study illustrates that lignocaine is better then ondansetron on preventation of injection pain caused by etomidate during induction of anesthesia
